Sort by
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Long Non-Coding RNA
40%
Stem Cell
35%
Long Noncoding RNA
32%
BMI1
22%
Cell Migration
21%
Cancer Cell
20%
Regulatory Network
19%
Osteoblast
19%
Messenger RNA
18%
Carcinogenesis
15%
Transcriptome
15%
Gene Expression Profiling
15%
Drug Resistance
14%
Colony Formation
14%
Non-Coding RNA
14%
Myeloid
14%
Induced Pluripotent Stem Cell
14%
SOX4
14%
TPX2
14%
Doxorubicin
14%
T Cell
13%
CRISPR/Cas9
13%
Epigenetics
13%
Gene Expression
13%
Messenger RNA
12%
Transcription Factor EZH2
12%
RNA Sequencing
11%
Microarrays
11%
Ossification
11%
Cell Proliferation
11%
Disease Free Survival
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Messenger RNA
10%
HMGA2
10%
Cancer Model
10%
Transcriptomics
9%
Transforming Growth Factor
9%
Histone Modification
9%
Malignant Transformation
9%
FOXM1
9%
Subcellular Localization
9%
Gene Signature
9%
Interleukin-1
8%
RNA
8%
Tumor-Related Gene
8%
Cancer Staging
8%
Overall Survival
8%
Insulin-Like Growth Factor
8%
Mediator
7%
Keyphrases
Breast Cancer
35%
Triple-negative Breast Cancer
35%
MicroRNA
24%
MicroRNA Profiling
21%
Breast Cancer Subtypes
16%
BMI1
15%
Lipid Metabolism
14%
RNA Localization
14%
Breast Cancer Progression
14%
Doxorubicin-resistant
14%
Cytokine Signaling
14%
Acute Ischemic Stroke
14%
Long Non-coding RNA (LncRNA)
14%
TPX2
14%
Middle East and North Africa
14%
PTC-209
14%
Cyclin-dependent Kinase 4 (CDK4)
14%
Palbociclib
14%
Tumor
13%
Breast Cancer Model
11%
Qatar
11%
Functional Screen
10%
Cas9 Protein
10%
Transcriptomic Profiling
10%
Subtype-specific
9%
Doxorubicin
8%
MicroRNA Profile
8%
Mammalian Target of Rapamycin (mTOR)
8%
Breast Cancer Susceptibility
8%
LRP8
8%
Middle Eastern
8%
Interleukin-1β
7%
Therapeutic Targeting
7%
Lin28
7%
Tumorigenicity
7%
RNA Profiling
7%
Breast Cancer Patients
7%
Novel Therapeutic Targets
7%
Therapeutic Potential
7%
Doxorubicin-resistant Cells
7%
Transforming Growth Factor-β
7%
Circular RNA Profile
7%
Engineered T-cell Receptor
7%
Systemic Alterations
7%
MicroRNA-301a
7%
Advanced Colorectal Cancer
7%
TAGLN
7%
Tumor Migration
7%
A549 Lung Cancer Cells
7%
Steatosis
7%
Medicine and Dentistry
Breast Cancer
21%
microRNA
21%
Messenger RNA
14%
Palbociclib
14%
Gene Expression Profiling
11%
Myeloid-Derived Suppressor Cell
9%
Osteoblast
9%
In Vitro
8%
Antigen Presenting Cell
8%
Tumor Progression
8%
Ossification
8%
Neoplasm
7%
RNA Sequencing
7%
Breast Cancer Molecular Subtype
7%
Tumor
7%
Mitochondrion
7%
Cell Death
7%
Transgelin
7%
Prognostic Factor
7%
Transforming Growth Factor
7%
Malignant Transformation
7%
microRNA 375
7%
Nasopharynx Cancer
7%
microRNA 100
7%
Polo Like Kinase 1
7%
Endoplasmic reticulum
7%
Abexinostat
7%
Histone Modification
7%
Myeloid Cell
7%
Bone Marrow Stromal Cell
7%
Induced Pluripotent Stem Cell
7%
Histone Deacetylase
7%
Fluorouracil
7%
microRNA 101
7%
Transcription Factor EZH2
7%
Nasopharynx Carcinoma
7%
Hematopoietic Stem Cell
7%
microRNA 26a
7%
Breast Radiotherapy
7%
Phosphotransferase Inhibitor
7%
Phosphatidylinositide
7%
Pleiotropy
7%
Mesenchymal Stem Cell
7%
Ruxolitinib
7%
Breast Cancer Survival
7%
Hypoxia Inducible Factor
7%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
COVID-19
7%
Carcinogenicity
7%
Von Hippel-Lindau Tumor Suppressor
7%